Trials / Completed
CompletedNCT00684671
Evaluation of Immune Memory to Twinrix or Comparator by Challenge Dose Administration 4 Years After Primary Vaccination
Challenge Dose Administration of Twinrix™ or Comparator 4 Years After Primary Vaccination.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 506 (actual)
- Sponsor
- GlaxoSmithKline · Industry
- Sex
- All
- Age
- 41 Years
- Healthy volunteers
- Accepted
Summary
Only subjects who participated in the primary study will be invited to participate in the extension phase and the challenge dose phase of this study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Twinrix | Intramuscular injection, single dose in left deltoid. |
| BIOLOGICAL | Engerix-B | Intramuscular injection, single dose in left deltoid. |
| BIOLOGICAL | Havrix | Intramuscular injection, single dose in right deltoid. |
| BIOLOGICAL | HBVAXPRO | Intramuscular injection, single dose in the left deltoid. |
| BIOLOGICAL | Vaqta | Intramuscular injection, single dose in right deltoid. |
Timeline
- Start date
- 2008-05-26
- Primary completion
- 2008-11-03
- Completion
- 2008-11-03
- First posted
- 2008-05-28
- Last updated
- 2018-08-17
- Results posted
- 2009-12-03
Locations
2 sites across 2 countries: Belgium, Czechia
Source: ClinicalTrials.gov record NCT00684671. Inclusion in this directory is not an endorsement.